Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Joseph

Showing results (451-460 of 531) with videos related to

Pageof 54
Sort By:
ACS Nano|November 28, 2022
Transferring Micellar Changes to Bulk Properties via Tunable Self-Assembly and Hierarchical OrderingLisa Thomson, Daniel McDowall, Libby Marshall, et al.
Cancer|December 20, 2011
NRAS mutation status is an independent prognostic factor in metastatic melanomaJohn A Jakob, Roland L Bassett, Chaan S Ng, et al.
Cancer Immunology Research|April 12, 2017
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced MelanomaDaniel Y Wang, Zeynep Eroglu, Alpaslan Ozgun, et al.
CBE Life Sciences Education|June 6, 2007
A faculty team works to create content linkages among various courses to increase meaningful learning of targeted concepts of microbiologyGili Marbach-Ad, Volker Briken, Kenneth Frauwirth, et al.
Science Advances|October 13, 2021
Insertional activation of <i>STAT3</i> and <i>LCK</i> by HIV-1 proviruses in T cell lymphomasJohn W Mellors, Shuang Guo, Asma Naqvi, et al.
Plos Pathogens|August 31, 2022
HIV infected CD4+ T cell clones are more stable than uninfected clones during long-term antiretroviral therapyShuang Guo, Brian T Luke, Amy R Henry, et al.
Cancer|October 19, 2017
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanomaRobert R McWilliams, Jacob B Allred, Jessica A Slostad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancerLajos Pusztai, Jim Hou Zhen, Banu Arun, et al.
Cancer Research|May 14, 2013
Enhanced inhibition of ERK signaling by a novel allosteric MEK inhibitor, CH5126766, that suppresses feedback reactivation of RAF activityNobuya Ishii, Naoki Harada, Eric W Joseph, et al.
Arthritis and Rheumatism|April 13, 2011
Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohortFrancisco Silva, Philip Seo, Darrell R Schroeder, et al.
Pageof 54

Showing results (451-460 of 531) with videos related to

Sort By:
Pageof 54
ACS Nano|November 28, 2022
Transferring Micellar Changes to Bulk Properties via Tunable Self-Assembly and Hierarchical OrderingLisa Thomson, Daniel McDowall, Libby Marshall, et al.
Cancer|December 20, 2011
NRAS mutation status is an independent prognostic factor in metastatic melanomaJohn A Jakob, Roland L Bassett, Chaan S Ng, et al.
Cancer Immunology Research|April 12, 2017
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced MelanomaDaniel Y Wang, Zeynep Eroglu, Alpaslan Ozgun, et al.
CBE Life Sciences Education|June 6, 2007
A faculty team works to create content linkages among various courses to increase meaningful learning of targeted concepts of microbiologyGili Marbach-Ad, Volker Briken, Kenneth Frauwirth, et al.
Science Advances|October 13, 2021
Insertional activation of <i>STAT3</i> and <i>LCK</i> by HIV-1 proviruses in T cell lymphomasJohn W Mellors, Shuang Guo, Asma Naqvi, et al.
Plos Pathogens|August 31, 2022
HIV infected CD4+ T cell clones are more stable than uninfected clones during long-term antiretroviral therapyShuang Guo, Brian T Luke, Amy R Henry, et al.
Cancer|October 19, 2017
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanomaRobert R McWilliams, Jacob B Allred, Jessica A Slostad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancerLajos Pusztai, Jim Hou Zhen, Banu Arun, et al.
Cancer Research|May 14, 2013
Enhanced inhibition of ERK signaling by a novel allosteric MEK inhibitor, CH5126766, that suppresses feedback reactivation of RAF activityNobuya Ishii, Naoki Harada, Eric W Joseph, et al.
Arthritis and Rheumatism|April 13, 2011
Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohortFrancisco Silva, Philip Seo, Darrell R Schroeder, et al.
Pageof 54